OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc. under the contract SPE2DP26F5762 for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, as part of a delivery order issued under the broader contract SPE2DX25D9900. The award was officially posted on July 21, 2026, with an award date of May 14, 2026, and the total contract value is specified in the associated award documentation. This procurement falls under federal acquisition channels managed by the Department of Defense, with no specific small business set-aside designation noted. The product is intended for military medical use, and performance is expected to support DoD healthcare needs, though no specific delivery location or point of contact details are provided in the record. The contract reflects a standard federal procurement process aimed at ensuring sustained access to essential pharmaceuticals for deployed and domestic defense personnel.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
